The primary aim of NISAN is to conduct high quality epidemiological studies and clinical trials to improve the health and outcomes in people with major neurological disorders. Our current research programmes focus on:
Research with this aim is unique within the landscape of existing research groups in New Zealand.
NISAN is envisaged to be a hub for information sharing and the fostering of a more cohesive network of communication between existing research and clinical groups with interests in neuroepidemiology, public health, neurorehabilitation, neuropsychology and biostatistics.
This direction allows a cohesive approach to communicating and working collaboratively with other groups, both within and outside AUT. NISAN makes use of the current expertise within the School of Clinical Sciences, the School of Public Health and Psychosocial Studies, and relevant institutes and centres at AUT, and it extends their work into areas of growing national and international demand.
Currently available cardiovascular disease (CVD) risk assessment algorithms allow calculation of absolute risk of CVD (including stroke) but they are designed for use by health professionals and require a lab test to complete. One of the main challenges in effective stroke prevention for an individual is the lack of awareness about stroke symptoms and risk factors, as well as self-managing strategies to reduce their risk of stroke.
The New Zealand Applied Neurosciences Conference is held in Auckland, New Zealand. The next conference will be in September 2016. Watch this space for more information.